TFFYX
Price
$88.38
Change
-$0.61 (-0.69%)
Updated
Jul 13 closing price
Net Assets
1.45B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

TFFYX vs VSTSX

TFFYX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
TFFYX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TFFYX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. TFFYX (1.45B). VSTSX pays higher dividends than TFFYX: VSTSX (1.07) vs TFFYX (0.36). TFFYX was incepted earlier than VSTSX: TFFYX (27 years) vs VSTSX (10 years). TFFYX (0.87) is less costly to investors than VSTSX (0.01). TFFYX is a more actively managed with annual turnover of: 6.00 vs. VSTSX (3.00). TFFYX has a lower initial minimum investment than VSTSX: TFFYX (2500) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. TFFYX (11.76). VSTSX return over 5 years is better than : 66.56 vs. TFFYX (41.13).
TFFYXVSTSXTFFYX / VSTSX
Total Expense Ratio0.870.018,700%
Annual Report Gross Expense Ratio0.870.018,700%
Fund Existence27 years10 years-
Gain YTD6.00411.20554%
Front LoadN/AN/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.45B2.3T0%
Annual Yield % from dividends0.361.0734%
Returns for 1 year11.7621.4855%
Returns for 3 years46.7267.0670%
Returns for 5 years41.1366.5662%
Returns for 10 years135.84239.5357%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I